NCT00205907View on ClinicalTrials.gov

Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

April 30, 2007

Conditions
Pulmonary Emphysema
Interventions
BIOLOGICAL

BLVR Hydrogel

10 mL BLVR Hydrogel

Trial Locations (1)

52621

Chaim Sheba (Tel Hashomer) Medical Center, Ramat Gan

Sponsors

Lead Sponsor

Aeris Therapeutics
All Listed Sponsors
lead

Aeris Therapeutics

INDUSTRY

NCT00205907 - Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation | Biotech Hunter | Biotech Hunter